Sinteza receptora vitamina vitamina D3 je genetički kontrolrana. Ovaj receptor istovremeno funkcionira i kao sekundarna žučna i lithoholna kiselina. Receptor pripada porodici of trans-activnih transcripcijskih regulatornih factora i pokazuju sličnost sekvence sa receptorima steroidnih i tiroidnih hormona.[9]
Nizvodni ciljevi ovog nuklearnog receptora hormona su uključeni uglavnom u metabolizam minerala, iako receptor regulira i niz drugih metaboličkih puteva, kao što su oni koji su uključeni u imuni odgovor i rak.[10]
Receptor vitamina D ima važnu ulogu u reguliranju ciklusa rasta dlake. Gubitak gena VDR je, kod ekperimentalnih životinja, povezan sa gubitkom dlake[12]
|slušnog ježaExperimentalna proučavanja pokazuju da neligandirani VDR stupa u interakciju sa ragulacijskom ciljnom regijom gena cWnt (wnt signalni put) i slušnog ježa i pokreće ovaj put tokom postnatalnog ciklusa rasta dlake.[13]
Ove studije su otkrile nove akcije neligandskih VDR u reguliranju post-morfogenog ciklusa dlake.
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Moore DD, Kato S, Xie W, Mangelsdorf DJ, Schmidt DR, Xiao R, Kliewer SA (decembar 2006). "International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor". Pharmacol. Rev. 58 (4): 742–59. doi:10.1124/pr.58.4.6. PMID17132852.CS1 održavanje: upotreba parametra authors (link)
^Lisse TS, Chun RF, Rieger S, Adams JS, Hewison M (juni 2013). "Vitamin D activation of functionally distinct regulatory miRNAs in primary human osteoblasts". J Bone Miner Res. 28 (6): 1478–14788. doi:10.1002/jbmr.1882. PMID23362149.CS1 održavanje: upotreba parametra authors (link)
^Germain P, Staels B, Dacquet C, Spedding M, Laudet V (decembar 2006). "Overview of nomenclature of nuclear receptors". Pharmacol. Rev. 58 (4): 685–704. doi:10.1124/pr.58.4.2. PMID17132848.CS1 održavanje: upotreba parametra authors (link)
^Adorini L, Daniel KC, Penna G (2006). "Vitamin D receptor agonists, cancer and the immune system: an intricate relationship". Curr Top Med Chem. 6 (12): 1297–301. doi:10.2174/156802606777864890. PMID16848743.CS1 održavanje: upotreba parametra authors (link)
^Luderer HF, Demay MB (juli 2010). "The vitamin D receptor, the skin and stem cells". J. Steroid Biochem. Mol. Biol. 121 (1–2): 314–6. doi:10.1016/j.jsbmb.2010.01.015. PMID20138991.CS1 održavanje: upotreba parametra authors (link)
^Lisse TS, Saini V, Zhao H, Luderer HF, Gori F, Demay MB (septembar 2014). "The Vitamin D Receptor Is Required for Activation of cWnt and Hedgehog Signaling in Keratinocytes". Mol. Endocrinol. 28 (10): 1698–1706. doi:10.1210/me.2014-1043. PMID25180455.CS1 održavanje: upotreba parametra authors (link)
^Guzey M, Takayama S, Reed JC (decembar 2000). "BAG1L enhances trans-activation function of the vitamin D receptor". J. Biol. Chem. 275 (52): 40749–56. doi:10.1074/jbc.M004977200. PMID10967105.CS1 održavanje: upotreba parametra authors (link)
^ abcdeKitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D, Ogawa S, Unno K, Okubo M, Tokita A, Nakagawa T, Ito T, Ishimi Y, Nagasawa H, Matsumoto T, Yanagisawa J, Kato S (juni 2003). "The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome". Cell. 113 (7): 905–17. doi:10.1016/S0092-8674(03)00436-7. PMID12837248.CS1 održavanje: upotreba parametra authors (link)
^ abIto M, Yuan CX, Malik S, Gu W, Fondell JD, Yamamura S, Fu ZY, Zhang X, Qin J, Roeder RG (mart 1999). "Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators". Mol. Cell. 3 (3): 361–70. doi:10.1016/S1097-2765(00)80463-3. PMID10198638.CS1 održavanje: upotreba parametra authors (link)
^ abTagami T, Lutz WH, Kumar R, Jameson JL (decembar 1998). "The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators". Biochem. Biophys. Res. Commun. 253 (2): 358–63. doi:10.1006/bbrc.1998.9799. PMID9878542.CS1 održavanje: upotreba parametra authors (link)
^ abcdPuccetti E, Obradovic D, Beissert T, Bianchini A, Washburn B, Chiaradonna F, Boehrer S, Hoelzer D, Ottmann OG, Pelicci PG, Nervi C, Ruthardt M (decembar 2002). "AML-associated translocation products block vitamin D(3)-induced differentiation by sequestering the vitamin D(3) receptor". Cancer Res. 62 (23): 7050–8. PMID12460926.CS1 održavanje: upotreba parametra authors (link)
^Herdick M, Steinmeyer A, Carlberg C (juni 2000). "Antagonistic action of a 25-carboxylic ester analogue of 1alpha, 25-dihydroxyvitamin D3 is mediated by a lack of ligand-induced vitamin D receptor interaction with coactivators". J. Biol. Chem. 275 (22): 16506–12. doi:10.1074/jbc.M910000199. PMID10748178.CS1 održavanje: upotreba parametra authors (link)
^ abcZhang C, Baudino TA, Dowd DR, Tokumaru H, Wang W, MacDonald PN (novembar 2001). "Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription". J. Biol. Chem. 276 (44): 40614–20. doi:10.1074/jbc.M106263200. PMID11514567.CS1 održavanje: upotreba parametra authors (link)